相关实验视频
Updated: Jun 29, 2025

04:33
Methods for Detecting Cough and Airway Inflammation in Mice
Published on: August 2, 2024
616
改变的微生物肠肺轴在人类耐火性慢性咳的发病过程中的首次探索
Simone Baldi1, Alessio Fabbrizzi2, Leandro Di Gloria3
1Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.
Lung
|March 25, 2024
概括
耐药性慢性咳 (RCC) 与肠道和口腔微生物群的显著变化有关. 这些肠肺沟通的变化可能为治疗持续咳提供新的治疗点.
科学领域:
- 微生物组研究的研究.
- 肠肺轴 肠肺轴 肠肺轴
- 呼吸系统药物 呼吸系统药物
背景情况:
- 咳是一种自然的防御机制,但如果持续,可能会变得有害.
- 耐火性慢性咳 (RCC) 影响大约20%的人.
- 了解肠肺轴对于探索新的治疗策略至关重要.
研究的目的:
- 研究RCC患者肠道微生物群 (GM) 和口腔微生物群 (OM) 的变化.
- 描述RCC患者肠道和口腔微生物组的组成和功能变化.
- 探索肠肺沟通在耐火性慢性咳病变中的作用.
主要方法:
- 使用16S rRNA测序分析了RCC患者和健康对照组 (HC) 中的GM和OM组成.
- PICRUST2被用于微生物群落的功能概况.
- 气相色谱被用来测量便短链脂肪酸水平和无血清脂肪酸 (FFA) 丰度.
主要成果:
- 与HC相比,RCC患者在GM和OM中表现出增加的唾液α多样性和显著的β多样性.
- 在RCC患者的便和唾液样本中观察到Firmicutes/Bacteroidota比率的显著变化.
- 功能分析表明,脂聚糖生物合成和脂酸代谢途径在便中可能过度表达,以及RCC患者的血清FFA水平发生变化.
结论:
- 在RCC患者中发现了肠道和口腔微生物群组成和功能的显著差异.
- 这些发现凸显了肠肺沟通改变在RCC病变发生过程中的潜在作用.
- 这项研究表明,恢复ebiotic肠肺通信可能会导致RCC管理的新营养或药理干预措施.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Cystic Fibrosis: Pathogenesis
229
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
229
Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

